Project: A liposomal cisplatin formulation (LiPlaCis) and companion diagnostics in the treatment of ABC/RBC.

Acronym LiPlaCis -in-ABC/RBC (Reference Number: 10893)
Duration 01/02/2017
Project Topic We aim to advance the development of LiPlaCis in the treatment of advanced or refractory breast cancer (ABC/RBC) by using an advanced Drug Response Predictor (DRP) analysis, based on genomic information, as a Companion Diagnostic (CDx). The highly selected patient group containing LiPlaCis-sensitive patients will be randomised in a multi-center clinical phase II study exploring the efficacy, safety and tolerability of LiPlaCis compared to treatment of physician’s choice.
Network Eurostars 2
Call Eurostars Cut-Off 6

Project partner

Number Name Role Country
1 Smerud Medical Research International AS Coordinator Norway
2 Oncology Venture ApS Partner Denmark